Correlates and escitalopram treatment effects on sleep disturbance in patients with acute coronary syndrome: K-DEPACS and EsDEPACS

Sleep

Volumn 38, Issue 7, 2015, Pages 1105-1111C

  Kim, Jae Min ^a   Stewart, Robert ^b   Bae, Kyung Yeol ^a   Kang, Hee Ju ^a   Kim, Sung Wan ^a   Shin, Il Seon ^a   Hong, Young Joon ^a   Ahn, Youngkeun ^a   Jeong, Myung Ho ^a   Yoon, Jin Sang ^a  

^a Chonnam National University Medical School   (South Korea)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Acute coronary syndrome; Depression; Double blind study; Escitalopram; Sleep disorders

Indexed keywords

ESCITALOPRAM; PLACEBO; CITALOPRAM;

ACUTE CORONARY SYNDROME; ADULT; AGE; ARTICLE; CARDIOVASCULAR RISK; COMORBIDITY; CONTROLLED STUDY; CORRELATION ANALYSIS; CROSS-SECTIONAL STUDY; DEMOGRAPHY; DEPRESSION; DIABETES MELLITUS; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; LEEDS SLEEP EVALUATION QUESTIONNAIRE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEX DIFFERENCE; SLEEP DISORDER; SOUTH KOREA; TREATMENT DURATION; TREATMENT OUTCOME; ADOLESCENT; AGED; AGING; COMPLICATION; DEPRESSIVE DISORDER; DRUG EFFECTS; MIDDLE AGED; QUESTIONNAIRE; RISK FACTOR; SEXUAL DEVELOPMENT; SLEEP; SLEEP WAKE DISORDERS; VERY ELDERLY; YOUNG ADULT;

ACUTE CORONARY SYNDROME; ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; AGING; CITALOPRAM; CROSS-SECTIONAL STUDIES; DEPRESSION; DEPRESSIVE DISORDER; DOUBLE-BLIND METHOD; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; REPUBLIC OF KOREA; RISK FACTORS; SEX CHARACTERISTICS; SLEEP; SLEEP WAKE DISORDERS; SURVEYS AND QUESTIONNAIRES; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84938057808     PISSN: 01618105     EISSN: 15509109     Source Type: Journal    
DOI: 10.5665/sleep.4822     Document Type: Article

References (51)

1. Foley D, Ancoli-Israel S, Britz P, Walsh J. Sleep disturbances and chronic disease in older adults: results of the 2003 National Sleep Foundation Sleep in America Survey. J Psychosom Res 2004;56:497-502.
2. Taylor DJ, Mallory LJ, Lichstein KL, Durrence HH, Riedel BW, Bush AJ. Comorbidity of chronic insomnia with medical problems. Sleep 2007;30:213-8.
3. Coryell VT, Ziegelstein RC, Hirt K, Quain A, Marine JE, Smith MT. Clinical correlates of insomnia in patients with acute coronary syndrome. Int Heart J 2013;54:258-65.
4. Kim JM, Stewart R, Kim SW, Yang SJ, Shin IS, Yoon JS. Insomnia, depression, and physical disorders in late life: a 2-year longitudinal community study in Koreans. Sleep 2009;32:1221-8.
5. Katz DA, McHorney CA. The relationship between insomnia and health-related quality of life in patients with chronic illness. J Fam Pract 2002;51:229-35.
6. Leineweber C, Kecklund G, Janszky I, Akerstedt T, Orth-Gomér K. Poor sleep increases the prospective risk for recurrent events in middle-aged women with coronary disease. The Stockholm Female Coronary Risk Study. J Psychosom Res 2003;54:121-7.
7. Murray CJL, Vos T, Lazano R, et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012;380:2197-223.
8. Bengtson A, Karlsson T, Herlitz J. Differences between men and women on the waiting list for coronary revascularization. J Adv Nurs 2000;31:1361-7.
9. Billing E, Eriksson SV, Hjemdahl P, Rehnqvist N. Psychosocial variables in relation to various risk factors in patients with stable angina pectoris. J Intern Med 2000;247:240-8.
10. Edéll-Gustafsson U, Svanborg E, Swahn E. A gender perspective on sleeplessness behavior, effects of sleep loss, and coping resources in patients with stable coronary artery disease. Heart Lung 2006;35:75-89.
11. Johansson I, Karlson BW, Grankvist G, Brink E. Disturbed sleep, fatigue, anxiety and depression in myocardial infarction patients. Eur J Cardiovasc Nurs 2010;9:175-80.
12. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 4th ed. Washington, DC: American Psychiatric Press I nc., 1994.
13. Roose SP, Laghrissi-Thode F, Kennedy JS, et al. Comparison of paroxetine and nortriptyline in depressed patients with ischemic heart disease. JAMA 1998;279:287-91.
14. Strik JJ, Honig A, Lousberg R, et al. Effcacy and safety of fuoxetine in the treatment of patients with major depression after frst myocardial infarction: fndings from a double-blind, placebo-controlled trial. Psychosom Med 2000;62:783-9.
15. Glassman AH, O'Connor CM, Califf RM, et al. Sertraline treatment of major depression in patients with acute MI or unstable angina. JAMA 2002;288:701-9.
16. Lespérance F, Frasure-Smith N, Koszycki D, et al. Effects of citalopram and interpersonal psychotherapy on depression in patients with coronary artery disease: the Canadian Cardiac Randomized Evaluation of Antidepressant and Psychotherapy Effcacy (CREATE) trial. JAMA 2007;297:367-79.
17. Kim JM, Bae KY, Kang HJ, et al. Design and methodology for the Korean observational and escitalopram treatment studies of depression in acute coronary syndrome: K-DEPACS and EsDEPACS. Psychiatry Investig 2014;11:89-94.
18. Hong YJ, Jeong MH, Ahn Y, Kang JC. The effcacy and safety of drug-eluting stents in patients with acute myocardial infarction: results from Korea Acute Myocardial Infarction (KAMIR). Int J Cardiol 2013;163:1-4.
19. Anderson JL, Adams CD, Antman EM, et al. 2012 ACCF/AHA focused update incorporated into the ACCF/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2013;61:e179-347.
20. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry 1961;4:561-71.
21. Sheehan DV, Lecrubier Y, Sheehan KH, et al. The mini-international neuropsychiatric interview (M.I.N.I): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 1998;59:S22-33.
22. Kim JM, Bae KY, Jung BO, et al. Escitalopram treatment for depressive patients with acute coronary syndrome: a 24 week double blind placebo controlled trial. J Clin Psychiatry 2015;76:62-8.
23. Parrot AC, Hindmarch I. The Leeds Sleep Evaluation Questionnaire in psychopharmacological investigation-a review. Psychopharmacology ( Be rl) 1980;71:173-9.
24. Killip T, Kimball JT. Treatment of myocardial infarction in a coronary care unit. A two year experience with 250 patients. Am J Cardiol 1967;20:457-64.
25. Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry 1979;134:382-9.
26. Ohayon MM. Epidemiology of insomnia: what we know and what we still need to learn. Sleep Med Rev 2002;6:97-111.
27. Budhiraja R, Roth T, Hudgel DW, Budhiraja P, Drake CL. Prevalence and polysomnographic correlates of insomnia comorbid with medical disorders. Sleep 2011;34:859-67.
28. Haaramo P, Rahkonen O, Hublin C, Laatikainen T, Lahelma E, Lallukka T. Insomnia symptoms and subsequent cardiovascular medication: a register-linked follow-up study among middle-aged employees. J Sleep Res 2014;23:281-9.
29. Vaz Fragoso, Gill TM. Sleep complaints in community-living older persons: a multifactorial geriatric syndrome. J Am Geriatr Soc 2007;55:1853-66.
30. Stein DJ, Lopez AG. Effects of escitalopram on sleep problems in patients with major depression or generalized anxiety disorder. Adv Ther 2011;28:1021-37.
31. Ensrud KE, Joffe H, Guthrie KA, et al. Effect of escitalopram on insomnia symptoms and subjective sleep quality in healthy perimenopausal and postmenopausal women with hot fashes: a randomized controlled trial. Menopause 2012;19:848-55.
32. Kátai Z, Adori C, Kitka T, et al. Acute escitalopram treatment inhibits REM sleep rebound and activation of MCH-expressing neurons in the lateral hypothalamus after long term selective REM sleep deprivation. Psychopharmacology (Berl) 2013;228:439-49.
33. Zajecka J, Schatzberg A, Stahl S, Shah A, Caputo A, Post A. Effcacy and safety of agomelatine in the treatment of major depressive disorder: a multicenter, randomized, double-blind, placebo-controlled trial. J Clin Psychopharmacol 2010;30:135-44.
34. Stein DJ, Lopez AG. Effects of escitalopram on sleep problems in patients with major depression or generalized anxiety disorder. Adv Ther 2011;28:1021-37.
35. Marin JM, Carrizo SJ, Vicente E, Agusti AG. Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet 2005;365:1046-53.
36. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960;23:56-62.
37. Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry 1979;134:382-9.
38. Beck AT, Ware CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry 1961;4:561-71.
39. Guy W. ECDEU Assessment manual for psychopharmacology. Revised. Rockville, MD: National Institute of Mental Health, 1976.
40. Davidson KW, Kupfer DJ, Bigger JT, et al. Assessment and treatment of depression in patients with cardiovascular disease: National Heart, Lung, and Blood Institute Working Group Report. Psychosom Med 2006;68:645-50.
41. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 4th ed. Washington, DC: American Psychiatric Press Inc., 1994.
42. Eipping-Jordan J, Ustun TB, Assessment, classifcation and epidemiology group. The WHODAS II: levelling the playing feld for all disorders. WHO Mental Health Bull 2000;6:5-6.
43. The WHOQOL Group. Development of the World Health Organization WHOQOL-BREF quality of life assessment. Psychol Med 1998;28:551-8.
44. Fava GA, Ruini C, Belaise C. The concept of recovery in major depression. Psychol Med 2007;37:307-17.
45. Ahn YM, Lee KY, Yi JS, et al. A validation study of the Korean-version of the Montgomery-Asberg Depression Rating Scale. J Korean Neuropsychiatr Assoc 2005;44:466-76.
46. Chung YC, Rhee MK, Lee YH, et al. Standardization study of Beck Depression Inventory 1-Korean version (K-BDI): reliability and factor analysis. Korean J Psychopathol 1995;4:77-95.
47. Kim JM, Stewart R, Glozier N, et al. Physical health, depression and cognitive function as correlates of disability in an older Korean population. Int J Geriatr Psychiatry 2005;20:160-7.
48. Lee J Y, Cho MJ, Kwon JS. Global assessment of functioning scale and social and occupational functioning scale. Korean J Psychopharmacol 2006;17:122-7.
49. Yi JS, Bae SO, Ahn YM, et al. Validity and reliability of the Korean version of the Hamilton Depression Rating Scale (K-HDRS). J Korean Neuropsychiatr Assoc 2005;44:456-65.
50. Yoo SW, Kim YS, Noh JS, et al. Validity of Korean version of the MiniInternational Neuropsychiatric Interview. Anxiety Mood 2006;2:50-5.
51. Kim SY, Kim JM, Yoo JA, et al. Standarization and validation of Big Five Inventory-Korean Version(BFI-K) in elders. Korean J Biol Psychiatry 2010;17:15-25.